You just need a good vitamin store.
%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
Exactly what are you referring to and can you post any links to evidence of how they help with covid?
Sure, I can. I have treated myself since April 2020 without even a cold.
* * * * * * *
The Importance of Zinc and Quercetin During Pandemic (click here)
* * * * * * *
COVID 19 Protocols for Prevention and Treatment (click here)
* * * * * * *
Results.* * * * * * *While both groups were moderate in size, the difference between them in outcomes over the 20-week study period was large and stark: Just under 4% of the compliant test group presented flu-like symptoms, but none of the test group was COVID-positive; whereas 20% of the non-compliant control group presented flu-like symptoms, three-quarters of whom (15% overall of the control group) were COVID-positive.
Conclusions.
Offering a low cost, readily implemented anti-viral approach, the study regimen may serve, at the least, as a stopgap modality and, perhaps, as a useful tool in combatting the pandemic.
I actually was clued in by some earlier papers, but access to them through the links I copied at the time have disappeared. Hmm.
The quercetin has been found in vitamin stores across the country, but not generally in pharmacies. You may have to search around. I got my latest batch here:
The daily supplement dosages O have been ingesting every day is
o Quercetin (kwur sit in) 500 mgI have been taking an aspirin, a B12 tablet, and a B Complex tablet as well, but tese are only secondary amd for other reasons not related to COVID-19. Never experiences of uncomfortable reactions from any of these.
o Vitamin C 1,400 mg
o Zinc (from zinc oxide or zinc gluconate) 50 mg
o vitamin D3 2 capdules x 2,000 mg per capsule = 4,000 mg
Fare thee well, my FRiend!
Vitamin D and an aspirin costs about 5 cents a day. There is evidence both cut the risk of catching COVID and cut the risk of dying if one does. Before the vaccines, people in my age group had a 1/200 chance of dying if they caught COVID. If aspirin and D cut that by 50%, then my risk was down to 1/400.
“Veterans from across the country with a first positive COVID-19 polymerase chain reaction lab result were included in the evaluation which comprised 35,370 patients from March 2, 2020 to September 13, 2020 for the 14-day mortality cohort and 32,836 patients from March 2, 2020 to August 28, 2020 for the 30-day mortality cohort. Patients were matched via propensity scores and the odds of mortality were then compared. Among COVID-19 positive Veterans, preexisting aspirin prescription was associated with a statistically and clinically significant decrease in overall mortality at 14-days (OR 0.38, 95% CI 0.32–0.46) and at 30-days (OR 0.38, 95% CI 0.33–0.45), cutting the odds of mortality by more than half.”
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0246825
“Aspirin use was associated with lower likelihood of COVID-19 infection, as compared to nonusers (adjusted OR 0.71 (95% CI, 0.52 to 0.99; P = 0.041). Aspirin users were older (68.06 ± 12.79 vs. 56.63 ± 12.28 years of age; P < 0.001), presented a lower BMI (28.77 ± 5.4 vs. 30.37 ± 4.55; P < 0.0189), and showed higher prevalence of hypertension (56, 76.71%), diabetes (47, 64.38%), and COPD (11, 15.07%) than the aspirin nonusers (151, 25.64%, P < 0.001; 130, 22.07%, P < 0.001; and 43, 7.3%, P = 0.023, respectively). Moreover, COVID-19 disease duration (considered as the time between the first positive and second negative COVID-19 RT-PCR test results) among aspirin users was significantly shorter, as compared to aspirin nonusers (19.8 ± 7.8 vs. 21.9 ± 7.9 P = 0.045). Among hospitalized COVID-positive patients, a higher proportion of surviving subjects were treated with aspirin (20, 19.05%), as opposed to 1 dead subject (14.29%), although this difference was not significant (P = 0.449). In conclusion, we observed an inverse association between the likelihood of COVID-19 infection, disease duration and mortality, and aspirin use for primary prevention.”
https://pubmed.ncbi.nlm.nih.gov/33621437/
“Aspirin lowers risk of COVID: New findings support preliminary Israeli trial
The treatment reduced the risk of reaching mechanical ventilation by 44%. ICU admissions were lower by 43%, and an overall in-hospital mortality saw a 47% decrease.”
“Results: Twenty-one eligible studies were found to be relevant to the relationship between vitamin D and COVID-19 infection/outcomes (n=205,869). The D-CIMA meta-analysis showed that individuals with low serum vitamin D levels were 1.64 times (95% confidence interval [CI], 1.32 to 2.04; p<0.001) more likely to contract COVID-19. The D-CSMA meta-analysis showed that people with serum 25(OH)D levels below 20 ng/mL or 50 nmol/L were 2.42 times (95% CI, 1.13 to 5.18; p=0.022) more likely to have severe COVID-19. The D-CMMA meta-analysis showed that low vitamin D levels had no effect on COVID-19 mortality (OR, 1.64; 95% CI, 0.53 to 5.06, p=0.390).”
https://pubmed.ncbi.nlm.nih.gov/34607398/